dr. han on the differences between cdk 4/6 inhibitors in er breast cancer
Published 6 years ago • 438 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
4:35
hr breast cancer: differences between cdk4/6 inhibitors
-
7:59
what are cdk 4/6 inhibitors for breast cancer?
-
2:19
cdk 4/6 inhibitors for patients with recurrent er /her2- breast cancer: 2023 best of breast
-
3:33
cdk 4/6 inhibitors in metastatic breast cancer
-
2:27
dr. o’shaughnessy on differentiating between cdk 4/6 inhibitors
-
1:54
cell cycle inhibitors - cdk4/6 inhibitors
-
26:08
metastatic hormone positive breast cancer | 2023 ku breast cancer year in review conference
-
7:13
the biological rationale for cdk4/6 inhibitors
-
1:36
dr. mahtani on the use of cdk 4/6 inhibitors in metastatic er breast cancer
-
20:19
expert discussion on cdk 4/6 inhibition in breast cancer
-
1:14:37
individualizing the selection of first-line therapy for patients with hr-positive metastatic bc
-
1:57
impact of cdk4/6 inhibitors on hr-positive, her2-negative advanced breast cancer
-
4:52
future directions: cdk4/6 inhibitors in breast cancer
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
2:11
the use of frontline cdk4/6 inhibitors endocrine therapy in metastatic breast cancer
-
1:02:43
realizing the potential of cdk 4/6 inhibitor therapy in breast cancer: real-world data and evidence
-
1:53
dr. finn on the inhibition of cdk 4/6 in breast cancer
-
0:57
evaluating the benefits of selective cdk4 inhibition in hr /her2- breast cancer
-
29:09
interactive case: choosing and using cdk4/6 inhibitors in breast cancer - first-line therapy
-
3:35
the benefits of adjuvant cdk4/6 and parp inhibition in breast cancer
-
8:28
cdk4/6 inhibition in breast cancer
-
2:22
cdk4/6 inhibitors in early stage hr /her2- disease